Table 4.
Distribution of Demographic Variables and Tumor Characteristics of Interest and Multivariable-Adjusted ORs and 95% CIs for Each Variable and Vital Status at Discharge Among 10,210 Individuals with COVID-19 Hospitalization and Prior Cancer Diagnosis
| Variable | Cancer cases deceased at discharge from COVID-19 hospitalization (n = 2,328), n (%) | Cancer cases alive at discharge from COVID-19 hospitalization (n = 7,882), n (%) | P value* | OR (95% CI)** |
|---|---|---|---|---|
| Age in years, mean (SD) | 77.9 (10.9) | 72.8 (13.3) | <.0001 | |
| Age group (y) | <.0001 | |||
| 0-19 | <11 | 30 (0.4) | NA | |
| 20-29 | <11 | 37 (0.5) | 0.24 (0.03-1.81) | |
| 30-39 | <11 | 69 (0.9) | 0.26 (0.06-1.13) | |
| 40-49 | 26 (1.1) | 241 (3.1) | Ref | |
| 50-59 | 99 (4.3) | 742 (9.4) | 1.29 (0.82-2.04) | |
| 60-69 | 365 (15.7) | 1,676 (21.3) | 2.16 (1.41-3.29) | |
| 70-79 | 726 (31.2) | 2,523 (32.0) | 3.02 (1.99-4.58) | |
| >80 | 1,109 (47.6) | 2,564 (32.5) | 4.85 (3.19-7.38) | |
| <.0001 | ||||
| Male | 1,415 (60.8) | 4,212 (53.4) | 1.33 (1.20-1.46) | |
| Female | 913 (39.2) | 3,670 (46.6) | Ref | |
| Race/ethnicity | 0.001 | |||
| Non-Hispanic White | 1,352 (58.1) | 4,924 (62.5) | Ref | |
| Non-Hispanic Black | 482 (20.7) | 1,448 (18.4) | 1.32 (1.16-1.51) | |
| Non-Hispanic API | 121 (5.2) | 333 (4.2) | 1.39 (1.1 1-1.75) | |
| Hispanic | 356 (15.3) | 1,101 (14.0) | 1.28 (1.11-1.49) | |
| Non-Hispanic other/unknown | 17 (0.7) | 76 (1.0) | 0.85 (0.50-1.47) | |
| Region of residency*** | <.0001 | |||
| New York City | 1,159 (49.8) | 3,359 (42.6) | 1.26 (1.13-1.40) | |
| Rest of New York State | 1,169 (50.2) | 4,523 (57.4) | Ref | |
| Stage of Cancer | 0.005 | |||
| Local | 1,072 (46.1) | 3,854 (48.9) | Ref | |
| Regional | 354 (15.2) | 1,274 (16.2) | 1.07 (0.92-1.23) | |
| Distant | 474 (20.4) | 1,509 (19.1) | 1.12 (0.98-1.30) | |
| Unknown stage | 428 (18.4) | 1,245 (15.8) | 1.12 (0.98-1.29) | |
| Multiple Tumor | 0.012 | |||
| No | 1,901 (81.7) | 6,611 (83.9) | Ref | |
| Yes | 427 (18.3) | 1,271 (16.1) | 1.03 (0.91-1.18) | |
| Time since cancer diagnosis | 0.003 | |||
| 0-2 years (2019-2021) | 411 (17.7) | 1,429 (18.1) | 0.96 (0.83-1.13) | |
| 3-5 years (2016-2019) | 521 (22.4) | 1,764 (22.4) | 1.02 (0.89-1.17) | |
| 6-10 years (2012-2016) | 492 (21.1) | 1,912 (24.3) | 0.87 (0.76-0.99) | |
| >10 years (1976-201 1) | 904 (38.8) | 2,777 (35.2) | Ref | |
| Active cancer diagnosis | <.0001 | |||
| Cancer diagnosis claim code | 793 (34.1) | 2,340 (29.7) | 1.39 (1.23-1.58) | |
| No cancer diagnosis claim code | 1,535 (65.9) | 5,542 (70.3) | Ref | |
*
P-values from χ2 tests for categorical variables and Student's t test for mean age.
**
Analyses mutually adjusted for all variables in the table.
***
Region of residency determined based on patient address at COVID-19 hospitalization from data obtained from SPARCS.